LONDON, June 27, 2016 /PRNewswire/ -- This BCC Research study defines and measures the global antibiotics market. It forecasts the revenue of the global antibiotics market and strategically analyzes each submarket with respect to individual growth trends and contribution to the overall antibiotics market. Includes forecast through 2020.
Use this report to:
Analyze the market structure by identifying the various subsegments of the global antibiotics market.
Identify major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets.
Analyze the opportunities in the market for the stakeholders by identifying the high-growth segments of the market.
Categorize the systemic antibiotics market by product and by application.
Highlights
The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.
The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.
The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2002.
STUDY GOALS AND OBJECTIVES
Define and measure the global antibiotics market.
Analyze the market structure by identifying the various subsegments of the global antibiotics market.
Forecast the revenue of the global antibiotics market and strategically analyze each submarket with respect to individual growth trends and contribution to the overall antibiotics market.
Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets.
Analyze the opportunities in the market for the stakeholders by identifying the high–growth segments of the market.
Profile the key players in the global antibiotics market and comprehensively analyze their core competencies and market share.
REASONS FOR DOING THE STUDY
The discovery of the first antibiotic nearly a century ago revolutionized the global healthcare industry, reducing the incidence of the morbidity and mortality due to dangerous infectious diseases. Global spending on medicines is forecast to reach nearly $1.3 trillion by 2018, an increase of about 30% over the 2013 level. The primary reasons for this growth are the introduction of new specialty medicines and increased accessibility for patients, which coincides with lower impacts from expiring patents in developed markets. There is expected to be an increase in the per capita spending on pharmaceuticals. Antibiotics represent approximately 4.5% of the global pharmaceutical market.
The global antibiotics market is estimated to have been nearly $41.0 billion in 2015 and is expected to reach $44.7 billion in 2020. The global aging population, rise in infectious diseases, increased prevalence of hospital-acquired infections and new drugs launched are the primary factors driving the growth of the antibiotics market. Most of the growth is expected from the two Asian giants; China and India. Economic conditions and cost–containment issues have compelled North American and European antibiotic manufacturers to explore new regions, such as India, China and Brazil, for growth opportunities.
There has been a paradigm shift in the regulatory framework, causing a positive impact on the overall growth of the antibiotics market; however, the economic slowdown and the negative impact of generics will limit the growth of the market. In order to keep abreast of this change, antibiotic manufacturers are using various novel technologies to reduce antibiotic resistance in order to yield novel antibiotics.
It is expected that this trend will continue with the aim of solving the current challenges and fulfilling the unmet needs of the market. North America accounted for the largest market in 2013 followed by Europe. However, Asian countries represent the fastest–growing markets due to the increasing aging population, increasing GDP rate
and increasing awareness about healthcare.
The leading players in the global antibiotics market include Pfizer Inc. (U.S.), Merck and Co. (U.S.), Eli Lilly and Co. (U.S.), Sanofi–Aventis (France), AstraZeneca (U.K.), Cubist pharmaceuticals (U.S.), Johnson & Johnson (U.S.) and GlaxoSmithKline PLC (U.K.).
Download the full report: https://www.reportbuyer.com/product/2158727/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article